This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We would like to inform you that the deadline for submitting articles for the special collection on Artificial Intelligence in Cardiovascular Health has been extended to March 1, 2024. We look forward to your contribution to enrich this special edition!
The International Journal of Cardiovascular Sciences has extended the deadline for article submissions to the special issue on Artificial Intelligence in Cardiovascular Health until August 30, 2025 ! Publications in this collection will continue until December 2025. More information: revistaijcs@cardiol.br
Insights into technology and what the future holds for MRI, CT and more were among our most viewed articles by far. As we reviewed our most popular publications of 2023, it became clear that many of you continue to rethink the limits of your profession. We’ll continue to bring you these insights and many more in 2024.
It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials.
For 75 years, the ACC has led in providing cutting-edge, innovative education to cardiovascular clinicians, ensuring they have the latest knowledge and skills to optimize patient care and outcomes. This month, Cardiology highlights three examples of ACC Education in action.
In this first episode, ACC Chief Innovation Officer Dr. Ami Bhatt is joined by Drs. Amey Vrudhula and Lily Stern to delve into artificial intelligence (AI) model training and how to leverage AI for early screening of cardiac amyloidosis.
Textile-based sensors and polymer-based stents came out on top in this year's annual Innovation Pitch Challenge, part of the Future Hub activities organized by the College's Health Care Innovation Section.
A late-breaking session at AHA 2024 highlighted new research focusing on “Smart Cardiology†innovations, including artificial intelligence (AI), aimed at improving heart health.
Innovation, celebration and connection were the underlying themes of this year's Opening Showcase, which paid homage to ACC's 75th Anniversary, showcased local Atlanta talent and highlighted all the "what-not-to-miss" elements of ACC.24.
These are the words that come to mind for the leaders of this year's Annual Scientific Session, which is taking over Atlanta, GA, for three days of the best cardiovascular (CV) science and innovation.
2024 was a year of innovation across the imaging spectrum. When we reviewed our top articles of the year, it became clear that what resonated more than anything else were in-depth looks at technology, the cost of that technology, and the myriad other innovations changing the clinical conversation.
Greetings from the Health Care Innovation Council! As with all our sister committees across the College, we have welcomed a new group to our Innovation Section and Leadership Team and are enthusiastic to tackle the coming years.
In 1949, 13 cardiologists led by Franz Groedel, MD, MACC, and Bruno Kisch, MD, MACC, founded the ACC, creating a professional home for cardiovascular clinicians seeking the latest science, research and cutting-edge education.
In recent years, the emergence of smartphones and microelectromechanical systems has allowed innovative solutions for conveniently measuring HR, such as smartphone ECG, smartphone photoplethysmography (PPG), and seismocardiography (SCG). The seven selected articles’ sample sizes varied from 11 to 435 participants.
The article also includes links to DAIC channels (on peripheral artery disease, stroke, heart failure, peripheral artery disease, cardiovascular clinical studies, and more) focused on specific areas of news coverage. In noting what the statistics show, and cardiology community sees daily, the FactMR report adds that the U.S.
Exploring the molecular mechanisms of mitophagy in hypertension-mediated organ damage could represent a critical avenue for future research in the development of innovative therapeutic modalities. Therefore, this article provides a comprehensive review of the impact of mitophagy on organ damage due to hypertension.
This article reports a case of a patient in whom a migrated LACbes device was successfully retrieved using a catheter-based approach, demonstrating an innovative and minimally invasive treatment strategy.
This article examines the strategies for using engineered exosomes to protect cardiac function and treat septic cardiomyopathy. It covers three innovative aspects: exosome surface modification technology, the use of exosomes as a multifunctional drug delivery platform, and plant exosome-like nanoparticle carriers.
For the busy cardiologists, this will a be refreshing reminder, that there are other important organs and specialties do exist in medicine , with equal breakthroughs and Innovations. Notable articles of 2023 from NEJM. Baxdrostat, an Aldosterone synthase antagonist for treatment-resistant Hypertension, appears promising (BrigHTN).
Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.
Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. He has published over 250 peer-reviewed articles and lectures extensively worldwide.
MD, MS, the “Beyond the Abstract” program explores the “whys” behind articles in The Annals of Thoracic Surgery and discusses next steps with authors and thought leaders. Podcast #80: Beyond the Abstract: STS 2021 and Recommendations for Hosting a Virtual Surgical Meeting Hosted by Thomas K. Varghese Jr., In the latest episode, Juan A.
This year's honorees represent an inspiring group of individuals who have made, and continue to make, significant contributions to advancing the Colleges Vision of a world where science, knowledge, and innovation enhance the care and outcomes of cardiovascular patients globally.
The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heart disease.
The history behind the ACC Women in Cardiology (WIC) Member Section reaches back 30 years and is a captivating narrative of empowerment, innovation, resilience and, ultimately, progress.
Protocols, best practices and practical insights to help clinicians successfully navigate remote patient management (RPM) are the focus of a new workbook released by the ACC Innovation Program.
Visage Imaging showcased a series of new product additions and innovations, as well as its Visage 7 Enterprise Imaging Platform, engineered for CloudPACS, at RSNA23. He added, “The implication of cloud over on-premise PACS deployments is they can more easily flex as their needs grow.
As the new year begins, the landscape of cardiovascular medicine is undergoing a remarkable transformation, driven by groundbreaking technologies and innovative approaches that promise to revolutionize patient care.
The TRAIN-HEART consortium, a Marie Skłodowska-Curie Actions Innovative Training Network (MSCA-ITN) funded by the European Commission, was established with the goal of filling that gap and developing RNA-based cardiovascular therapeutics.
In this article, we discuss the importance of translating digital innovations in research‐funded projects to low‐resource settings globally to advance global cardiovascular health equity. Cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide.
I would also like to thank my predecessor, Professor Catherine Otto, and her team, who brought numerous innovations to elevate the journal’s value over the past 10 years. Building on her legacy, my goal over the coming years is to increase the impact of the journal further.
As the health care field continues to evolve, NCDR is committed to helping facilities measure and improve the quality of care they provide with the most relevant data elements and metrics, actionable insights and more.
These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.
The authors of an article published in Cardiovascular Innovations and Applications deployed a deep learning (DL)-based handheld device to facilitate symptom-driven monitoring. Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of post-ablation atrial fibrillation recurrence (AFR).
Krumholz, MD, SM, FACC, started his official term as JACC editor-in-chief on July 1. In an interview with Cardiology, he shares his vision for JACC's future as a beacon to advance cardiovascular health for all.
Most of the published research was clinical, with limited innovative contributions and a preference for regional journals. About one-quarter of the published articles (26%) resulted from collaborative efforts among multiple countries, with the United States being the most frequent collaborator.
Previous to GWU, Earls served as Medical Director and Vice President at Fairfax Radiological Consultants (FRC) in Fairfax, VA, where he was an early innovator and clinical adopter of coronary CT angiography. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies.
This article delves into the evolution, current implementations, and future directions of CS teams, emphasizing their crucial role in enhancing patient outcomes. Emerging evidence indicates that structured, team-based approaches significantly improve survival rates and diminish complications linked to CS.
Lipi Roy and Amit Goyal to explore innovative strategies in cardiovascular education, media engagement, and leadership empowerment. In this episode, hosted by the ACC Women in Cardiology (WIC) Advocacy Work Group, Drs. Kamala Tamirisa and Keerthana Pakanati welcome distinguished guests Drs.
Alongside quantifiable factors such as salary and benefits, hospital size, patient volume, and work schedule, qualitative factors like innovation also come into play. And you can't talk about innovation without technology. This article was originally published on AuntMinnie.com on August 21, 2023.
In this second episode in a three-part series of episodes focusing on artificial intelligence (AI) in cardiology, Dr. Effie Andrikopoulou hosts Dr. Nishath Quader and Mr. Demetri Giannikopoulos to discover how innovative AI solutions can tackle one of the biggest challenges facing todays cardiologistsburnout.
Increasing diversity in clinical trial enrollment may impact who receives early application of recently approved innovations, based on findings from a study conducted on behalf of the Heart Failure Collaboratory and being presented at ACC.24 24 in Atlanta, GA.
In this special edition of Eagle’s Eye View, Dr. Eagle highlights the latest science and innovation being presented at ACC.24 24 in Atlanta, Georgia from April 6-8. He gives us valuable insights into practice-changing updates in care. The topics include late-breaking clinical trials and science focusing on new drugs and device therapies.
24, which brought together the world of cardiology for three days of celebration, innovation, connection and so much more. This issue of Cardiology celebrates the resounding success of ACC.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content